v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Private Placement
Underwritten Offering
Common Stock
Common Stock
Private Placement
Common Stock
Underwritten Offering
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Underwritten Offering
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2022       150,448,363              
Beginning balance at Dec. 31, 2022 $ 411,853     $ 15     $ 893,850     $ (1,041) $ (480,971)
Exercise of stock options, shares       199,344              
Exercise of stock options 183           183        
Vesting of early exercised stock options 243           243        
Stock-based compensation expense 6,845           6,845        
Net loss (33,199)                   (33,199)
Unrealized gain (loss) on marketable securities, net 527                 527  
Ending balance, shares at Mar. 31, 2023       150,647,707              
Ending balance at Mar. 31, 2023 386,452     $ 15     901,121     (514) (514,170)
Beginning balance, shares at Dec. 31, 2022       150,448,363              
Beginning balance at Dec. 31, 2022 411,853     $ 15     893,850     (1,041) (480,971)
Net loss (64,980)                    
Ending balance, shares at Jun. 30, 2023       151,042,118              
Ending balance at Jun. 30, 2023 362,705     $ 15     909,434     (793) (545,951)
Beginning balance, shares at Mar. 31, 2023       150,647,707              
Beginning balance at Mar. 31, 2023 386,452     $ 15     901,121     (514) (514,170)
Exercise of stock options, shares       170,715              
Exercise of stock options 122           122        
Issuance of common stock under the Employee Stock Purchase Plan 527           527        
Issuance of common stock under the Employee Stock Purchase Plan, Shares       223,696              
Vesting of early exercised stock options 652           652        
Stock-based compensation expense 7,012           7,012        
Net loss (31,781)                   (31,781)
Unrealized gain (loss) on marketable securities, net (279)                 (279)  
Ending balance, shares at Jun. 30, 2023       151,042,118              
Ending balance at Jun. 30, 2023 $ 362,705     $ 15     909,434     (793) (545,951)
Beginning balance, shares at Dec. 31, 2023 151,462,103     151,462,103              
Beginning balance at Dec. 31, 2023 $ 316,686     $ 15     922,607     77 (606,013)
Exercise of stock options, shares       35,035              
Exercise of stock options 24           24        
Vesting of early exercised stock options 155           155        
Stock-based compensation expense 6,848           6,848        
Net loss (35,017)                   (35,017)
Unrealized gain (loss) on marketable securities, net (287)                 (287)  
Ending balance, shares at Mar. 31, 2024       151,497,138              
Ending balance at Mar. 31, 2024 $ 288,409     $ 15     929,634     (210) (641,030)
Beginning balance, shares at Dec. 31, 2023 151,462,103     151,462,103              
Beginning balance at Dec. 31, 2023 $ 316,686     $ 15     922,607     77 (606,013)
Net loss $ (98,218)                    
Ending balance, shares at Jun. 30, 2024 273,163,958     273,163,958              
Ending balance at Jun. 30, 2024 $ 451,087     $ 27     1,155,487     (196) (704,231)
Beginning balance, shares at Mar. 31, 2024       151,497,138              
Beginning balance at Mar. 31, 2024 288,409     $ 15     929,634     (210) (641,030)
Issuance of common stock   $ 43,604 $ 174,426   $ 2 $ 10   $ 43,602 $ 174,416    
Issuance of common stock, share         21,844,660 99,459,458          
Exercise of stock options, shares       110,258              
Exercise of stock options 105           105        
Issuance of common stock under the Employee Stock Purchase Plan 395           395        
Issuance of common stock under the Employee Stock Purchase Plan, Shares       252,444              
Vesting of early exercised stock options 155           155        
Stock-based compensation expense 7,180           7,180        
Net loss (63,201)                   (63,201)
Unrealized gain (loss) on marketable securities, net $ 14                 14  
Ending balance, shares at Jun. 30, 2024 273,163,958     273,163,958              
Ending balance at Jun. 30, 2024 $ 451,087     $ 27     $ 1,155,487     $ (196) $ (704,231)